Navigation Links
Grubb & Ellis Healthcare REIT II Declares Initial Distribution
Date:12/14/2009

SANTA ANA, Calif., Dec. 14 /PRNewswire/ -- Grubb & Ellis Healthcare REIT II, Inc. announced today that its board of directors has authorized a daily distribution to stockholders of record as of the close of business on each day of the period commencing on Jan. 1, 2010 and ending on Feb. 28, 2010. The distributions will be calculated based on 365 days in the calendar year and will be equal to an annualized distribution rate of 6.5 percent, assuming a purchase price of $10.00 per share. These distributions will be aggregated and paid in cash monthly in arrears. The distributions declared for each record date in January and February would be paid in February and March, respectively.

Grubb & Ellis Company, the sponsor of the REIT, will fund these distributions in the event the REIT has not acquired a property during such period. Grubb & Ellis Company will not receive any additional shares of the REITs' common stock nor any other remuneration for funding these distributions. Further, Grubb & Ellis Healthcare REIT II will not repay the funds provided by Grubb & Ellis Company.

About Grubb & Ellis Healthcare REIT II

Grubb & Ellis Healthcare REIT II, Inc. intends to qualify as a real estate investment trust that seeks to preserve, protect and return investors' capital contributions, pay regular cash distributions, and realize growth in the value of its investments upon the ultimate sale of such investments. Grubb & Ellis Healthcare REIT II is seeking to raise up to approximately $3 billion in equity and to acquire a diversified portfolio of real estate assets, focusing primarily on medical office buildings and other healthcare-related facilities.

Grubb & Ellis Healthcare REIT II is sponsored by Grubb & Ellis Company ( GBE). Named to The Global Outsourcing 100(TM) in 2009 by the International Association of Outsourcing Professionals(TM), Grubb & Ellis is one of the largest commercial real estate services and investment companies in the world. Our 6,000 professionals in more than 130 company-owned and affiliate offices draw from a unique platform of real estate services, practice groups and investment products to deliver comprehensive, integrated solutions to real estate owners, tenants and investors. The firm's transaction, management, consulting and investment services are supported by highly regarded proprietary market research and extensive local expertise. Through its investment subsidiaries, the company is a leading sponsor of real estate investment programs that provide individuals and institutions the opportunity to invest in a broad range of real estate investment vehicles, including publicly registered non-traded real estate investment trusts (REITs), tenant-in-common (TIC) investments suitable for tax deferred 1031 exchanges, separate accounts and other real estate investment funds. For more information, visit www.grubb-ellis.com.

This release contains certain forward-looking statements (under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) with respect to our ability to acquire a property, our ability to pay a distribution to our stockholders upon our acquisition of a property, or our ability to pay subsequent distributions beyond the period our sponsor will fund distributions. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, but are not limited to, the following: the availability, quality and purchase price of medical office buildings and healthcare- related facilities for sale; uncertainties relating to changes in general economic and real estate conditions; uncertainties regarding changes in the healthcare industry; the uncertainties relating to the implementation of our real estate investment strategy; and other risk factors as outlined in the company's prospectus, as amended from time to time, and as detailed from time to time in our periodic reports, as filed with the Securities and Exchange Commission. Forward-looking statements in this document speak only as of the date on which such statements were made, and we undertake no obligation to update any such statements that may become untrue because of subsequent events. We claim the safe harbor protection for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.

THIS IS NEITHER AN OFFER TO SELL NOR AN OFFER TO BUY ANY SECURITIES DESCRIBED HEREIN. OFFERINGS ARE MADE ONLY BY MEANS OF A PROSPECTUS OR OFFERING MEMORANDUM.

SOURCE Grubb & Ellis Healthcare REIT II, Inc.


'/>"/>
SOURCE Grubb & Ellis Healthcare REIT II, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Grubb & Ellis Healthcare REIT II Declared Effective by the U.S. Securities and Exchange Commission
2. Grubb & Ellis Healthcare REIT Signs Agreement to Purchase 16 Building Medical Office Portfolio
3. Grubb & Ellis Healthcare REIT Acquires 185,000 SF Wisconsin Medical Office Buildings Portfolio
4. Grubb & Ellis Healthcare REIT Acquires Mountain Plains Portfolio in Texas
5. Grubb & Ellis Healthcare REIT Acquires Oklahoma City Medical Portfolio
6. Scott D. Peters to Continue as Chairman and CEO of Grubb & Ellis Healthcare REIT
7. Grubb & Ellis Healthcare REIT Acquires Senior Care Portfolio 1 in Calif.
8. Grubb & Ellis Healthcare REIT Acquires Decatur Medical Plaza in Decatur, Ga.
9. Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis
10. Grubb & Ellis Healthcare REIT Acquires SouthCrest Medical Plaza in Stockbridge, Ga.
11. Grubb & Ellis Healthcare REIT Acquires Nutfield Professional Center in Derry, N.H.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Linda, Ca (PRWEB) , ... February 27, 2017 ... ... Life Sciences, provides an overview on laser diffraction analysis as a tool to ... its capabilities, significance and potential to obtain improved results and novel scientific findings. ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast ... in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the ... Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... 25, 2017 , ... The February 13, 2017, assassination of Kim Jong-nam, the ... agents and the deadly use of chemical weapons. Many questions exist about the effect ... doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017 Mederi Therapeutics today announced the ... 2468 patients who received  Stretta Therapy  to treat ... Systematic Review and Meta-Analysis of Controlled and Prospective ... of Gastroesophageal Reflux Disease ", was published in ... , MD, head of the Esophageal and Swallowing ...
(Date:2/27/2017)... Feb. 27, 2017  International Biophysics Corporation, a global medical ... today announced a 34% revenue growth in 2016 when compared ... unit sales.  This growth was fueled by its AffloVest® sales ... to the expansion of its global sales of surgical product ... CEO, "As we enter our 25 th year in ...
(Date:2/27/2017)... 2017  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ... 37 th Annual Healthcare Conference on Monday, March ... Boston, MA. A live webcast of Infinity,s ... Infinity,s website at www.infi.com , and will be ... About Infinity,Infinity is an innovative biopharmaceutical company dedicated to ...
Breaking Medicine Technology: